4th Quarter - Report

BROWN RUDNICK LLP for PRIME THERAPEUTICS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues relating to generic pharmaceutical utilization and prescription drug abuse under the Medicare Part D prescription drug program. Implementation of the Biologics Price Competition and Innovation Act (BPCIA)

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen. Stabenow (05-07)
HENRY W MENN CoS, Sen. Bob Graham (01 - 04)

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

HR 4577 - Ensuring Seniors Access to Local Pharmacies Act of 2014

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen. Stabenow (05-07)
HENRY W MENN CoS, Sen. Bob Graham (01 - 04)

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4577 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.